IQVIA Pharma Deals Half-Year Review of 2025

By Lucy Haggerty,Taskin Ahmed, Ayush Saxena & Shikha Kashyap

Pharma Deals Review: Vol 2025 Issue 9 (Table of Contents)

Published: 18 Sep-2025

DOI: 10.3833/pdr.v2025.i9.2970     ISSN: 1756-7874

Section: Opinion & Analysis

Fulltext:

Abstract

After an underwhelming 2024 on the dealmaking front, deal activity in the life sciences sector remained muted in the first half of 2025 as caution prevailed amid continued macroeconomic pressures and rising geopolitical tensions...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details